Filing Flows › Nutex Health (NUTX) › Q3 2026
Nutex Health (NUTX) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Nutex Health (NUTX) reported revenue of $218M for the third quarter 2026 (Q3 2026), -19% from a year earlier and +3% from the quarter before. Operating margin was 35.4%, net earnings $40.2M (18.5% of revenue).
Nutex Health, Q3 2026: revenue $218M (-19% year over year), operating margin 35.4%, net earnings $40.2M, operating cash flow $78.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $218M | +3% | -19% |
| Gross profit | $102M | -28% | -34% |
| Operating profit | $77.1M | -37% | -41% |
| Net earnings | $40.2M | -39% | -27% |
| Operating cash flow | $78.3M | +129% | -21% |
| Free cash flow | $73.1M | +131% | -26% |
What changed
Revenue was $217.6M in Q3 2026, down 19% year over year and up 3% from the previous quarter. Hospital division revenue was the largest line at 96% of revenue. Hospital division revenue lost $51.1M year over year (down 20%), 102% of the total change.
Gross margin was 46.7%, down 11.2 points from Q3 2025. Operating profit was $77.1M, a 35.4% margin (down 13.3 points year over year). Operating expenses fell 0% while revenue fell 19%. The fastest-growing cost line was General & admin (+51%). Net earnings were $40.2M, down 27% year over year. The effective tax rate was 20.9%.
Operating cash flow was $78.3M (down 21% year over year), 137% of net income including minority interests. Non-cash charges added back $5.6M of depreciation and amortization. Working capital and other items added $15.4M. Capital expenditures of $5.2M left free cash flow of $73.1M.
Questions
What was Nutex Health's revenue in the third quarter 2026?
Nutex Health (NUTX) reported revenue of $218M for the third quarter 2026 (Q3 2026), -19% from a year earlier and +3% from the quarter before.
Was Nutex Health profitable in the third quarter 2026?
Operating profit was $77.1M (35.4% of revenue) and net earnings $40.2M.
Source: Nutex Health 10-Q on SEC EDGAR.